Thalassemia
Advertisement
Differences were identified between patient racial groups and by urban versus rural populations.
A magnetic resonance imaging study has compared tissue iron levels and biventricular function between the two conditions.
An ongoing phase IIA study reports safety and dosing data for patients with transfusion-dependent disease.
Myeloablation followed by exa-cel infusion brought transfusion independence to β-thalassemia patients in a phase III trial.
Dr. Vadivelan shared her study on pituitary and pancreatic iron deposition in patients with SCD at the 2024 ASPHO Conference.
Exa-cel eliminated RBC transfusions in patients with transfusion-dependent β-thalassemia.
The European Commission has approved the Conditional Marketing Authorization for exagamglogene autotemcel.
Direct-acting antiviral therapy was safe and effective in pediatric patients with thalassemia who contracted hepatitis C.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.